CN Patent
CN119700771A — 吡啶并吡嗪衍生物用于制备治疗白血病药物的用途
Assigned to Sun Yat Sen University Cancer Center · Expires 2025-03-28 · 1y expired
What this patent protects
本发明公开了一种吡啶并吡嗪衍生物或其盐用于制备治疗白血病药物的用途。如式(I)所示的吡啶并吡嗪衍生物或其盐用于制备治疗白血病药物的用途。
USPTO Abstract
本发明公开了一种吡啶并吡嗪衍生物或其盐用于制备治疗白血病药物的用途。如式(I)所示的吡啶并吡嗪衍生物或其盐用于制备治疗白血病药物的用途。
Drugs covered by this patent
- Synribo (OMACETAXINE MEPESUCCINATE) · Teva Pharms Intl
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.